| Recent development in peptide coupling reagents TI Al-Warhi, HMA Al-Hazimi, A El-Faham Journal of Saudi Chemical Society 16 (2), 97-116, 2012 | 257 | 2012 |
| Recent advancements of coumarin-based anticancer agents: An up-to-date review T Al-Warhi, A Sabt, EB Elkaeed, WM Eldehna Bioorganic Chemistry 103, 104163, 2020 | 201 | 2020 |
| Antibacterial, Antioxidant Activity of Ethanolic Plant Extracts of Some Convolvulus Species and Their DART‐ToF‐MS Profiling A Al-Rifai, A Aqel, T Al-Warhi, SM Wabaidur, ZA Al-Othman, ... Evidence‐based Complementary and Alternative Medicine 2017 (1), 5694305, 2017 | 108 | 2017 |
| Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents WM Eldehna, GS Hassan, ST Al-Rashood, T Al-Warhi, AE Altyar, ... Journal of enzyme inhibition and medicinal chemistry 34 (1), 322-332, 2019 | 80 | 2019 |
| Development of isatin-thiazolo [3, 2-a] benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and … WM Eldehna, MA El Hassab, MF Abo-Ashour, T Al-Warhi, MM Elaasser, ... Bioorganic Chemistry 110, 104748, 2021 | 75 | 2021 |
| Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies WM Eldehna, ST Al-Rashood, T Al-Warhi, RO Eskandrani, A Alharbi, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 271-286, 2021 | 69 | 2021 |
| Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological … T Al-Warhi, AAM Sallam, LR Hemeda, MA El Hassab, N Aljaeed, ... Pharmaceuticals 15 (10), 1262, 2022 | 65 | 2022 |
| Discovery of 3, 6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights A Sabt, WM Eldehna, T Al-Warhi, OJ Alotaibi, MM Elaasser, H Suliman, ... Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 1616-1630, 2020 | 63 | 2020 |
| 3-Methylthiazolo [3, 2-a] benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and … AAM Alkhaldi, MM Al-Sanea, A Nocentini, WM Eldehna, ZM Elsayed, ... European Journal of Medicinal Chemistry 207, 112745, 2020 | 61 | 2020 |
| Synthesis, biological evaluation and in silico studies of certain oxindole–indole conjugates as anticancer CDK inhibitors T Al-Warhi, AM El Kerdawy, N Aljaeed, OE Ismael, RR Ayyad, ... Molecules 25 (9), 2031, 2020 | 58 | 2020 |
| Benzofuran-based carboxylic acids as carbonic anhydrase inhibitors and antiproliferative agents against breast cancer WM Eldehna, A Nocentini, ZM Elsayed, T Al-Warhi, N Aljaeed, OJ Alotaibi, ... ACS Medicinal Chemistry Letters 11 (5), 1022-1027, 2020 | 55 | 2020 |
| Novel [(N-alkyl-3-indolylmethylene) hydrazono] oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and in … T Al-Warhi, MF Abo-Ashour, H Almahli, OJ Alotaibi, MM Al-Sanea, ... Journal of enzyme inhibition and medicinal chemistry 35 (1), 1300-1309, 2020 | 55 | 2020 |
| Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR … WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi, H Elkady, ... Scientific reports 12 (1), 12821, 2022 | 50 | 2022 |
| Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria ZM Elsayed, WM Eldehna, MM Abdel-Aziz, MA El Hassab, EB Elkaeed, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 384-392, 2021 | 50 | 2021 |
| Strawberry and ginger silver nanoparticles as potential inhibitors for SARS-CoV-2 assisted by in silico modeling and metabolic profiling MM Al-Sanea, N Abelyan, MA Abdelgawad, A Musa, MM Ghoneim, ... Antibiotics 10 (7), 824, 2021 | 49 | 2021 |
| Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular … MA El Hassab, AA Shoun, ST Al-Rashood, T Al-Warhi, WM Eldehna Frontiers in Chemistry 8, 584894, 2020 | 43 | 2020 |
| Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer WM Eldehna, R Salem, ZM Elsayed, T Al-Warhi, HR Knany, RR Ayyad, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1423-1434, 2021 | 38 | 2021 |
| Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII T Al-Warhi, MM Elbadawi, A Bonardi, A Nocentini, AA Al-Karmalawy, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2635-2643, 2022 | 36 | 2022 |
| Antioxidant and Wound Healing Potential of Vitis vinifera Seeds Supported by Phytochemical Characterization and Docking Studies T Al-Warhi, EM Zahran, S Selim, MM Al-Sanea, MM Ghoneim, SA Maher, ... Antioxidants 11 (5), 881, 2022 | 36 | 2022 |
| Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors T Al-Warhi, AA Al-Karmalawy, AA Elmaaty, MA Alshubramy, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 176-191, 2023 | 28 | 2023 |
